To claim credit for the sessions you attended, please click on the data below. Please note, that you must have attended the applicable live session to claim credit.
Immunotherapies have yielded impressive clinical benefits in a growing number of cancers, and in many cases, they have surpassed the efficacy of existing therapies. Immunotherapy usage is expected to increase in cancer care with the rapid approval of several new drugs and expanded indications for existing drugs in this class. However, the expanding armamentarium of immunotherapies available to treat patients with cancer poses a challenge to community clinicians with respect to integrating this new class of agents into practice. Community cancer programs need guidance regard the practical issues that cancer programs must navigate to provide immunotherapy safely and effectively in their own communities.
Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the Association of Community Cancer Centers.
Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the Association of Community Cancer Centers.
Contact Hours: 1.00, of which 1.0 is pharmacology credit worthy